EA200200801A1 - Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия - Google Patents

Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия

Info

Publication number
EA200200801A1
EA200200801A1 EA200200801A EA200200801A EA200200801A1 EA 200200801 A1 EA200200801 A1 EA 200200801A1 EA 200200801 A EA200200801 A EA 200200801A EA 200200801 A EA200200801 A EA 200200801A EA 200200801 A1 EA200200801 A1 EA 200200801A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dose
fsh
infertility
treatment
follicle
Prior art date
Application number
EA200200801A
Other languages
English (en)
Other versions
EA004924B1 (ru
Inventor
Эрнест Лумей
Луиз Дьюр-Майерз
Original Assignee
Апплайд Резеч Системз Арс Холдинг Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26072975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200200801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP00302840A external-priority patent/EP1142582A1/en
Application filed by Апплайд Резеч Системз Арс Холдинг Н.В. filed Critical Апплайд Резеч Системз Арс Холдинг Н.В.
Publication of EA200200801A1 publication Critical patent/EA200200801A1/ru
Publication of EA004924B1 publication Critical patent/EA004924B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к применению FSH и/или его биологически активного аналога для получения лекарственного средства для лечения бесплодия у женщин. Это лекарственное средство предназначено для введения в первоначальной дозе в диапазоне от 100 до 600 ME с последующей второй дозой, по меньшей мере, 3 дня спустя в фазе стимуляции. В одном варианте лекарственное средство предназначено для введения в дозе в диапазоне от 300 до 600 ME каждый третий день первых 6 дней фазы стимуляции. В другом варианте первоначальная доза находится в диапазоне от 100 до 500 ME, причем вторую дозу вводят при трех-шести, предпочтительно четырех днях после введения первоначальной дозы.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200801A 2000-01-27 2001-01-09 Способ лечения бесплодия у женщин с использованием фолликулостимулирующего гормона EA004924B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00300591 2000-01-27
EP00302840A EP1142582A1 (en) 2000-04-04 2000-04-04 Use of FSH for treating infertility
PCT/GB2001/000065 WO2001054715A1 (en) 2000-01-27 2001-01-09 Use of fsh for treating infertility

Publications (2)

Publication Number Publication Date
EA200200801A1 true EA200200801A1 (ru) 2003-02-27
EA004924B1 EA004924B1 (ru) 2004-10-28

Family

ID=26072975

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200801A EA004924B1 (ru) 2000-01-27 2001-01-09 Способ лечения бесплодия у женщин с использованием фолликулостимулирующего гормона

Country Status (29)

Country Link
US (1) US7291593B2 (ru)
EP (2) EP1442748A1 (ru)
JP (1) JP5170928B2 (ru)
KR (2) KR100871499B1 (ru)
CN (1) CN1418107A (ru)
AR (1) AR027287A1 (ru)
AT (1) ATE267608T1 (ru)
AU (1) AU783121B2 (ru)
BG (1) BG65915B1 (ru)
BR (1) BR0107881A (ru)
CA (1) CA2397680A1 (ru)
CZ (1) CZ302835B6 (ru)
DE (1) DE60103503T3 (ru)
DK (1) DK1250148T4 (ru)
EA (1) EA004924B1 (ru)
EE (1) EE05444B1 (ru)
ES (1) ES2217113T5 (ru)
HR (1) HRP20020630A2 (ru)
HU (1) HU230833B1 (ru)
IL (2) IL150837A0 (ru)
MX (1) MXPA02007233A (ru)
NO (1) NO324626B1 (ru)
PL (1) PL211113B1 (ru)
PT (1) PT1250148E (ru)
RS (1) RS50805B (ru)
SI (1) SI1250148T2 (ru)
SK (1) SK287717B6 (ru)
TR (1) TR200401810T4 (ru)
WO (1) WO2001054715A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003022302A2 (en) * 2001-09-12 2003-03-20 Applied Research Systems Ars Holding N.V. USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
PL369021A1 (en) * 2001-09-12 2005-04-18 Applied Research Systems Ars Holding N.V. Use of hcg and lh in controlled ovarian hyperstimulation
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US7481748B2 (en) * 2005-09-22 2009-01-27 Kurt Manufacturing Company, Inc. Locking mechanism for a bicycle trainer
WO2008140794A1 (en) * 2007-05-11 2008-11-20 The Texas A & M University System Hormone normalization therapy and uses thereof
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CA2934579A1 (en) * 2013-12-20 2015-06-25 Fertilify Inc. Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
AU2018326556A1 (en) * 2017-09-01 2020-03-05 Ferring B.V. Composition for controlled ovarian stimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins

Also Published As

Publication number Publication date
NO20023354L (no) 2002-09-24
JP2003520823A (ja) 2003-07-08
HUP0204324A3 (en) 2004-12-28
BG106943A (bg) 2003-02-28
BG65915B1 (bg) 2010-05-31
IL150837A0 (en) 2003-02-12
JP5170928B2 (ja) 2013-03-27
US20030158106A1 (en) 2003-08-21
NO20023354D0 (no) 2002-07-11
DE60103503D1 (de) 2004-07-01
ES2217113T5 (es) 2008-11-01
HRP20020630A2 (en) 2004-12-31
WO2001054715A1 (en) 2001-08-02
HUP0204324A2 (en) 2003-05-28
KR20020081273A (ko) 2002-10-26
CZ20022555A3 (cs) 2002-11-13
CN1418107A (zh) 2003-05-14
SI1250148T2 (sl) 2008-10-31
DE60103503T2 (de) 2005-06-09
TR200401810T4 (tr) 2004-09-21
KR100871499B1 (ko) 2008-12-05
EE200200415A (et) 2003-12-15
MXPA02007233A (es) 2003-02-12
SK287717B6 (en) 2011-07-06
HU230833B1 (hu) 2018-07-30
US7291593B2 (en) 2007-11-06
EP1250148B2 (en) 2008-07-02
EA004924B1 (ru) 2004-10-28
DE60103503T3 (de) 2008-12-24
PT1250148E (pt) 2004-09-30
DK1250148T3 (da) 2004-08-16
SK10962002A3 (sk) 2002-12-03
IL150837A (en) 2010-12-30
YU56702A (sh) 2005-09-19
ES2217113T3 (es) 2004-11-01
EE05444B1 (et) 2011-08-15
NO324626B1 (no) 2007-11-26
EP1442748A1 (en) 2004-08-04
CZ302835B6 (cs) 2011-11-30
RS50805B (sr) 2010-08-31
EP1250148A1 (en) 2002-10-23
AR027287A1 (es) 2003-03-19
DK1250148T4 (da) 2008-09-22
AU2532101A (en) 2001-08-07
PL356925A1 (en) 2004-07-12
SI1250148T1 (en) 2004-08-31
BR0107881A (pt) 2003-04-01
KR20070087253A (ko) 2007-08-27
KR100871502B1 (ko) 2008-12-05
AU783121B2 (en) 2005-09-29
ATE267608T1 (de) 2004-06-15
CA2397680A1 (en) 2001-08-02
EP1250148B1 (en) 2004-05-26
PL211113B1 (pl) 2012-04-30

Similar Documents

Publication Publication Date Title
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
DE69225135T2 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
RU2010101892A (ru) Гиалуронидаза и способ ее применения
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
KR910019618A (ko) 발기부전증 치료용 제약 조성물
RU2007104774A (ru) Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы
UY27378A1 (es) Composición farmacéutica
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
JP2006514092A5 (ru)
MX173567B (es) Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih
PT1001802E (pt) Preparacao farmaceutica combinada compreendendo a hormona da paratiroide e um inibidor de reabsorcao ossea
HUP0400553A2 (hu) Gyógyászati készítmények
EA200200801A1 (ru) Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия
JP2004537500A5 (ru)
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
AR012731A1 (es) Uso de un derivado de taxano para la preparacion de una composicion farmaceutica , uso de un agente mejorador de la biodicponibilidad de dicho derivado forma de dosificacion oral y conjunto afrmaceutico que lo comprende y metodo para formar a un agente activo biodisponible.
CY1108648T1 (el) Αναστολεας της αρωματασης σε μια δοση για την θεραπευτικη αντιμετωπιση της υπογόνιμοτήτας
JP2002530353A5 (ru)
MXPA02006511A (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido.
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
KR900011461A (ko) 트립스타틴을 유효성분으로 하는 치료제
WO2005048978A3 (en) A controlled release pharmaceutical composition and a process for preparing the same
RU2002129298A (ru) Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MK4A Patent expired

Designated state(s): AM AZ BY KZ KG MD TJ TM RU